However, the recent success of atypical antipsychotic drugs such as clozapine and risperidone has broken a 30 year trend during which pharmaceutical companies focused solely on D2 receptor antagonism in their quest for new drug treatments for schizophrenia. In the next few years, at least four ...
It's known that radiation and chemotherapy take a toll on the body in the short term but in a new study, treatments against breast cancer can also cause significant long term affects that speed up the aging process in survivors. Read more Finalists for the Zayed Sustainability Prize vie ...
Mabel Mardones, MD, board-certified medical oncologist and hematologist with an advanced subspecialty in breast cancer at Rocky Mountain Cancer Centers, led a discussion on new treatments for HR+/HER2– breast cancer at the Denver Regional Institute for Value-Based Medicine®. Mardones highlighted...
Treatments for schizophrenia: a critical review of pharmacology and mechanisms of action of antipsychotic drugs. Mol Psychiatry 2005; 10: 79–104. Article CAS PubMed Google Scholar Burstein ES, Ma J, Wong S, Gao Y, Pham E, Knapp AE et al. Intrinsic efficacy of antipsychotics at human D2...
ReCode is the first genetic medicines platform to enable highly targeted delivery to organs, tissues and cells beyond the liver. Our pipeline of rare disease therapeutics uses optimized mRNA and gene correction with redosing capability.
To measure the degree of these effects, Neuhaus and Popescu20,26 collated studies across conditions; including schizophrenia (total observation N = 5563), MDD (N = 2042), and attention deficit hyperactivity disorder (ADHD, N = 8084), finding an inverse relationship between sample ...
Substantial progress has been made towards the development of effective therapies and treatments for the multiple forms of Batten disease. In 2017, cerliponase alfa (Brineura), a tripeptidyl peptidase enzyme replacement therapy, became the first globally approved treatment for CLN2 Batten disease. ...
Harvey PD, Green MF, Keefe RS, Velligan DI:Cognitive functioning in schizophrenia: A consensus statement on its role in the definition and evaluation of effective treatments for the illness.J Clin Psychiatry 2004,65:361–372. Article PubMed Google Scholar Geyer MA, Tamminga CA:Measurement and...
consumers are often recommended treatments on a trial-and-error basis, and consumers are often unclear about the actions needed to address their behavioral health. even well-defined disorders can be notoriously difficult to categorize, diagnose, and treat. for example, research suggests that 70% of...
R Ganguly,LS Miller,BC Martin - 《Schizophrenia Research》 被引量: 0发表: 2003年 FUTURE EMPLOYABILITY: A NEW APPROACH TO COST〦FFECTIVENESS ANALYSIS OF ANTIPSYCHOTIC THERAPY Ganguly R, Miller LS, Martin BC (2003) Future employability, a new approach to cost-effectiveness analysis of antipsychoti...